MedTrace Logo

A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum

NCT05514782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2022-10-27

No results posted yet for this study

Summary

This double-blind, randomized, placebo-controlled, single-center clinical trial was conducted to assess the efficacy and tolerance of an anti-aging daily serum to improve moderate overall photodamage and skin fatigue after 12-weeks of twice-daily used when compared to a placebo-serum (vehicle control). A total of 62 subjects, 34-60 years of age completed study participation.

Conditions

  • Photoaging
  • Wrinkle

Interventions

OTHER

Cleansing Lotion

Facial cleansing lotion to be used by study participants (morning and evening, 2x daily).

OTHER

Facial Moisturizer

Anti-aging facial moisturizer to be used by study participants after anti-aging daily serum before sunscreen.

OTHER

Sunscreen SPF 40+

Sunscreen to be applied after application of the facial moisturizer in the morning. Participants were asked to reapply every 2 hours. Per FDA this intervention is an Over the counter

Sponsors & Collaborators

  • KGL, Inc.

    collaborator OTHER

  • Revision Skincare

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2021-12-10
Completion
2021-12-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05514782 on ClinicalTrials.gov